Product ID: SQMIG30I2309
Global Human Milk Oligosaccharides (HMO) Market Size, Share, Growth Analysis, By Type(2'-FL & 3-FL, Sialyllactose), By Application(Segmented as, Infant Formula) - Industry Forecast 2024-2031
Report ID:
SQMIG30I2309 |
Region:
Global |
Published Date: February, 2024
Pages:
157
|
Tables:
65 |
Figures:
75
Global Human Milk Oligosaccharides (HMO) Market News
- In January 2023, Danone declared that a new baby formula enhanced with HMOs would be available. The product, Aptamil Pronutra HA, is intended to support an infant's immune system and intestinal health.
- In February 2023, Nestlé declared that a new baby formula enhanced with HMOs would be available. Nido FortifiGrow+, the formula, is intended to assist newborns' intellectual growth.
- In March 2023, A study that was written up in the journal "Nature" suggested that HMOs might aid in defending newborns against respiratory illnesses. According to the study, babies who were given formula supplemented with HMOs had a lower risk of respiratory infections than babies who were given formula without HMOs.
- In April 2023, A study in the journal "Pediatrics" discovered that HMOs might assist in enhancing the gut microbiota of newborns. According to the study, babies who were given formula with HMOs added to it had a more balanced and diversified gut microbiota than babies who were given formula without HMOs.
Global Human Milk Oligosaccharides (HMO) Market Report Snapshots
Want to customize this report?
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATION
USA (+1) 351-333-4748
